Xeris Biopharma Holdings, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 83.1M | 85.8M | 74.4M | 71.5M | 60.1M | 60.1M | 54.3M | 48.1M |
| Cost of Goods Sold | 13.3M | 19.1M | 11.0M | 14.6M | 8.7M | 9.5M | 13.6M | 10.5M |
| Gross Profit | 69.8M | 66.7M | 63.4M | 56.9M | 51.4M | 50.6M | 40.7M | 37.6M |
| R&D Expenses | 8.8M | 7.9M | 7.5M | 8.1M | 7.8M | 6.1M | 5.9M | 5.8M |
| Operating Expenses | 61.9M | 50.0M | 56.7M | 52.4M | 54.5M | 48.9M | 53.6M | 45.8M |
| Operating Income | 7.9M | 16.8M | 6.7M | 4.5M | -3.1M | 1.7M | -12.9M | -8.2M |
| Other Income / Gains | -5.7M | -5.7M | -6.1M | -6.4M | -6.1M | -6.8M | -6.2M | -6.1M |
| Net Income | 2.2M | 11.1M | 621K | -1.9M | -9.2M | -5.1M | -15.7M | -15.0M |
| EPS (Diluted) | 0.013 | 0.067 | 0.003 | -0.012 | -0.061 | -0.034 | -0.11 | -0.10 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.84 | 0.778 | 0.852 | 0.796 | 0.855 | 0.842 | 0.75 | 0.782 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 53.1M | 47.5M | 46.5M | 44.4M | 44.0M | 40.1M | 45.0M | 40.0M |
| Other Expenses | 0 | -5.4M | 2.7M | 0 | 2.7M | 2.7M | 2.7M | 0 |
| Cost And Expenses | 75.2M | 69.0M | 67.6M | 67.1M | 63.2M | 58.4M | 67.2M | 56.3M |
| Interest Income | 1.2M | 1.5M | 1.2M | 948K | 1.2M | 910K | 1.2M | 1.3M |
| Interest Expense | 6.9M | 7.2M | 7.3M | 7.4M | 7.3M | 7.7M | 7.8M | 8.0M |
| Depreciation And Amortization | 3.2M | 3.0M | 3.2M | 3.2M | 3.1M | 3.1M | 3.1M | 3.2M |
| Ebitda | 12.3M | 14.1M | 11.1M | 8.6M | 1.2M | 5.7M | -8.2M | -3.1M |
| Ebitdaratio | 0.148 | 0.165 | 0.149 | 0.12 | 0.02 | 0.095 | -0.15 | -0.065 |
| Operating Income Ratio | 0.095 | 0.195 | 0.09 | 0.063 | -0.051 | 0.028 | -0.238 | -0.17 |
| Income Before Tax | 2.2M | 11.1M | 621K | -1.9M | -9.2M | -5.1M | -19.1M | -14.3M |
| Income Before Tax Ratio | 0.027 | 0.129 | 0.008 | -0.027 | -0.153 | -0.085 | -0.351 | -0.297 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | -3.3M | 749K |
| Net Income Ratio | 0.027 | 0.129 | 0.008 | -0.027 | -0.153 | -0.085 | -0.29 | -0.312 |
| Epsdiluted | 0.013 | 0.062 | 0.003 | -0.012 | -0.061 | -0.034 | -0.11 | -0.10 |
| Weighted Average Shs Out | 170.5M | 166.0M | 177.6M | 156.0M | 152.4M | 149.1M | 149.0M | 148.3M |
| Weighted Average Shs Out Dil | 177.6M | 180.1M | 177.6M | 156.0M | 152.4M | 149.1M | 149.0M | 148.3M |